PASADENA, Calif.--(BUSINESS WIRE)--Materia, Inc., a catalyst technology company, announced today the non-exclusive licensing of its metathesis platform to Merck & Co, Inc., a global pharmaceutical company, for use in the discovery and development of pharmaceuticals. No financial terms of the agreement were disclosed.
